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Case Report
Reversible pulmonary artery perfusion abnormalities in the
postpartum period as a precursor to the development of
pulmonary arterial hypertension
Devaki O’Riordan1, David G. Kiely2 and B. Ronan O’Driscoll1
1Manchester Academic Health Sciences Centre, Department of Respiratory Medicine, Salford Royal Foundation NHS Trust, Salford, Manchester, UK; 2Sheffield
Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, South Yorkshire, UK
Abstract
Deterioration, or a new presentation, of pulmonary arterial hypertension (PAH), are recognized complications of pregnancy. In this
report, we describe a patient with a family history of PAH who developed peripartum breathlessness and hypoxemia with
ventilation-perfusion mismatch but no evidence of thromboembolism or PAH. Significantly reduced perfusion at both lung
bases was noted on perfusion scintigraphy and three-dimensional magnetic resonance (3D-MR) perfusion maps in the immediate
postpartum period. These abnormalities spontaneously resolved by 16 weeks postpartum, consistent with reversible pulmonary
abnormalities of pulmonary perfusion. However, she developed new breathlessness four years later and was found to have
developed PAH. This case provides a mechanism which may contribute to the high mortality seen in pregnant patients with
PAH in the peripartum period.
Keywords
peripartum, scintigraphy, vasoconstriction, VQ scan in pregnancy
Date received: 19 August 2017; accepted: 14 April 2018
Pulmonary Circulation 2018; 8(3) 1–6
DOI: 10.1177/2045894018775190
This case report describes a patient with no known pulmon-
ary vascular disease, but with a family history of pulmonary
arterial hypertension (PAH), who developed hypoxemia
during late pregnancy and the puerperium. Abnormalities
of pulmonary artery perfusion in the immediate postpartum
period were noted on perfusion scintigraphy and three-
dimensional magnetic resonance (3D-MR) perfusion maps
which have not been previously described and which
resolved at follow-up. She developed PAH four years later.
Case report
Due to a family history of PAH, a 27-year-old asymptom-
atic, non-smoking Singaporean woman with no previous
medical history was referred to the cardiology clinic seven
weeks into her ﬁrst pregnancy to screen for pulmonary
hypertension (PH). Her father died of PAH at the age of
46 years and her sister (her only sibling) had been on treat-
ment for PAH for ﬁve years. To our knowledge, the family
had not had any genetic testing.
At presentation, the patient was asymptomatic at World
Health Organization Functional Class (WHO FC) I, with
oxygen saturations of 96% on air at rest. She underwent a
transthoracic echocardiogram which showed normal right
ventricular function and an estimated systolic pulmonary
artery pressure (PAP) of 16mmHg plus right atrial pressure
based on the tricuspid gradient.
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She was referred again at 34 weeks’ gestation with breath-
lessness on walking up hills (WHO FC II), with an oxygen
saturation of 93% on air at rest. Echocardiogram again
showed no evidence of PH with systolic PAP estimated at
21mmHg, and her dyspnea was felt to be due to her gravid
uterus and diaphragmatic splinting. Lung function tests
were not performed at this time.
At full term, she delivered a healthy baby girl by normal
vaginal delivery with a moderate postpartum hemorrhage
(dropping her hemoglobin from 153 g/L to 98 g/L). Of inter-
est, her platelet count also dropped modestly from 166 to
137 109/L (normal range¼ 150–400), but her clotting stu-
dies were normal (prothrombin time, APTT, and ﬁbrino-
gen). After delivery, her oxygen saturation fell from 93%
pre-delivery to 86–88% breathing air and she reported
increasing breathlessness on minimal exertion in WHO
FC III. Her chest was clear, her blood pressure and heart
sounds were normal, and she had no clinical evidence of
right or left heart strain. The electrocardiogram and plain
chest radiograph were normal.
She walked 75m slowly breathing air (over 80 s) and her
oxygen saturation dropped from 90% to 78%. There was no
positional variability in saturation. Spirometry revealed
normal volumes and ﬂow (FEV1/FVC¼ 2.98L [85% pre-
dicted]/3.69L [91% predicted]) but transfer factor (DLCO)
was reduced at 47% predicted. Other than her hemoglobin
and platelet counts as above, all blood tests including HIV
test, eosinophils, vasculitis, and autoimmune screens were
normal. Echocardiography showed an estimated systolic
PAP of 20mmHg plus right atrial pressure and good right
ventricular function.
A ventilation perfusion (VQ) scan performed one day
postpartum showed normal ventilation throughout, but
grossly reduced perfusion in both mid to lower zones, with
normal perfusion at the apices (Fig. 1). Computed tomog-
raphy pulmonary angiogram (CTPA) on the same day
showed no evidence of emboli or abnormal structural vas-
culature to correspond with the changes seen on VQ scan
(Figs. 2 and 3). She was treated with 2L/min oxygen therapy
and prophylactic low molecular weight heparin, and after a
Fig. 1. VQ scan performed on day 1 postpartum showing ventilation-perfusion mismatches in both mid to lower zones during period of hypoxia.
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further 48 h was able to maintain her oxygen saturation at
92% on air, although her desaturation on exercise remained
the same.
Given concerns regarding an uncharacterized pulmonary
vascular disorder she was referred to the regional PH refer-
ral center. Here, she underwent right heart catheterization
(RHC) 13 days after delivery, (right atrial
pressure¼ 7mmHg, pulmonary capillary wedge pressure
[PCWP]¼ 9mmHg, cardiac output¼ 5.17L/min, mean
PAP [mPAP]¼ 24mmHg [systolic PAP¼ 34mmHg/dia-
stolic PAP¼ 13mmHg], cardiac index¼ 3.68L/min/m2,
and pulmonary vascular resistance [PVR]¼ 232 dynes/s/
cm2). Following exercise on the catheter table, the heart
rate increased from 85 bpm to 120 bpm, with increases in
mPAP to 29mmHg, in PCWP to 12mmHg, and in cardiac
output to 8.2 L/min, with a fall in PVR of 166 dynes/s/cm2.
3D-MR perfusion maps 14 days postpartum showed a simi-
lar picture to the perfusion scan, with less ﬁlling of the ves-
sels inferiorly compared to apically (Fig. 4). MR also
demonstrated normal right and left ventricular function.
CTPA demonstrated no evidence of thromboembolic dis-
ease and no evidence of a right to left shunt. Overnight
oximetry on air showed a mean oxygen saturation of 87%
with frequent small desaturations, but no signiﬁcant apneas.
The patient was reviewed as an outpatient six weeks post-
partum, at which time she had become asymptomatic with
unlimited exercise tolerance. She climbed 90 18-cm steps in
3min without breathlessness and retained oxygen satur-
ations of 96% breathing air throughout. Fourteen weeks
after childbirth, she was reassessed at the regional referral
center. RHC demonstrated no change in mPAP at
23mmHg. A repeat isotope perfusion scan was now within
normal limits apart from very minimal patchy perfusion
defects at the lung bases (Fig. 5). 3D-MR perfusion map-
ping was also normal, with no evidence of signiﬁcant desat-
uration on maximal exercise testing (Fig. 6). Six months
after delivery, her transthoracic echocardiogram showed
an estimated systolic PAP of 23mmHg and she was asymp-
tomatic in WHO FC I.
Fig. 2. CTPA on day 1 showing no evidence of pulmonary thromboemboli or structural vascular abnormalities in the areas corresponding to
changes on the VQ scan.
Fig. 3. CTPA on day 1 showing no evidence of proximal pulmonary
artery obstruction.
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Fig. 4. MR perfusion map 14 days postpartum showing reduced filling
of vessels inferiorly compared to apically.
Fig. 5. Repeat VQ scan performed eight weeks after childbirth when patient was asymptomatic, showing complete resolution of previous
mismatched changes.
Fig. 6. MR image showing normal perfusion 14 weeks postpartum.
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She remained well for almost four years but then pre-
sented with exertional breathlessness in WHO FC II.
Her spirometry was normal but transfer factor (DLCO)
was 61% predicted. An echocardiogram showed new dila-
tion of the right ventricle with estimated systolic PAP
of 75mmHg. RHC conﬁrmed the presence of
signiﬁcant PAH with PAP of 90/35 (mean¼ 56mmHg),
a mean PAWP of 12mmHg, reduced cardiac output at
1.97L/min/m2, and an elevated PVR of 1200 dynes/s/cm2.
Cardiac MR scan demonstrated right ventricular impair-
ment with a right ventricular ejection fraction of 44%.
A repeat perfusion scan of the lungs remained normal (iden-
tical to Fig. 2) and did not show recurrence of the previous
abnormalities shown in Fig. 1.
Discussion
This case illustrates an unusual pulmonary vascular
response during the postpartum period, which has not
been previously described. It demonstrates reversible
changes in pulmonary perfusion occurring in a woman
with a family history of PAH but in the absence of PH. It
suggests an abnormal pulmonary vascular response which
may be one of a number of mechanisms responsible for the
high mortality seen in women with PAH in the immediate
postpartum period. In addition, this case describes the
development of PAH several years following the initial pres-
entation in pregnancy with complete resolution of symp-
toms in interim period.
PH has many causes which include idiopathic PAH, a
rare condition with a relentlessly progressive course and if
untreated has a median survival of <3 years.1 Studies have
suggested that 11–40% of patients with idiopathic disease
and 70% of patients with a family history of PAH have a
mutation in the BMPR2 gene.2 Similar rates of this gene
mutation are seen in PAH cohort studies in East Asian
populations.3 Importantly, so far there is no intervention
that will prevent the development of PAH in patients who
carry the genetic mutation.
Echocardiography studies of asymptomatic relatives of
patients with PAH have shown that although pulmonary
vascular pressures may be normal at rest, they can behave
abnormally in response to exercise or hypoxia.4 However,
current guidelines do not recommend the use of stress echo-
cardiography as a means of identifying early PAH due to the
lack of validated criteria and prospective data.5
The occurrence of PAH during pregnancy has been pos-
tulated to represent an unmasking of pre-existing disease
due to the increased cardiovascular demands of pregnancy,
or one of ‘‘multiple hits’’ that are thought to be required for
the development of PAH in patients who are predisposed to
develop the condition chronically, such as those with a
family history of PAH.
Pregnancy in PAH is associated with a high rate of
maternal death. Compared to previous decades, there has
been an overall improvement in mortality in PAH at 25%
versus 38% for all patients.6 More recent studies have sug-
gested improved outcomes when patients receive care in spe-
cialist centers with an overall mortality in the region of
10%.7,8 Mortality is particularly high in the immediate post-
partum period with the majority of deaths occurring in the
ﬁrst seven days postpartum.6 Pregnancy is a ‘‘vasodilatory’’
state with major changes occurring in the postpartum period
resulting in reversal of this state. During pregnancy, ﬂuctu-
ating levels of estradiol and progesterone aﬀect both physi-
ology and pathology in the lung.9 Hormonal mechanisms
may also be responsible for the well-recognized phenom-
enon of worsening PH in pregnancy in women with estab-
lished PAH.10 The fact that this patient’s condition
worsened temporarily in the postpartum period with regards
to oxygenation and pulmonary perfusion to the lung bases
raises the possibility that reversible pulmonary vasoconstric-
tion may play a part in postpartum pathophysiology.
Amniotic ﬂuid embolism should be considered as a dif-
ferential diagnosis here. However, this patient had breath-
lessness and mild hypoxemia from the 34th week of
pregnancy and she had no traumatic risk factors during
labor and she had an uneventful delivery. With no evidence
of cardiogenic shock or disseminated intravascular coagulo-
pathy (instead a ﬁnding of isolated thrombocytopenia
alone), a clinical diagnosis of amniotic ﬂuid embolism was
ruled out.11 Indeed, mother and baby had no neurological
sequelae consistent with this diagnosis.
It is interesting to note that this patient’s platelet count
dropped peripartum. The authors postulate that the devel-
opment of pulmonary microthrombi composed of platelets
and ﬁbrin may have been responsible for the transient
reduction in perfusion in the postpartum period, as seen in
PH in newborns.12 In patients with severe PAH, where there
is less vascular reserve, such an insult could potentially
explain why patients can decompensate rapidly in the imme-
diate postpartum period with an acute worsening of PH and
with severe hypoxemia that may not respond to vasodilator
therapy.
Generally, the physiological changes occurring in preg-
nancy return to normal within 3–6 months of delivery, and
indeed this patient became asymptomatic with a normal
oxygen saturation and normal pulmonary perfusion and
hemodynamics within this time. However, we note that
her mPAP remained at the high end of the normal range
(with a mPAP in the range of 20–24mmHg, albeit with a fall
in PVR on exercise) and with a persistently reduced transfer
factor (DLCO). The two CTPA scans were of suﬃciently
high quality to rule out chronic thromboembolic PH.13,14
The nature of this patient’s pulmonary vascular changes
was still indeterminate and prognosis unclear.
Consequently, she was counseled against pursuing another
pregnancy, and also in avoidance of estrogen-containing
contraception as intimal proliferation has been reported in
association with female reproductive steroids.15 The genetic
status of the patient and her family are not known and
ideally should be studied.
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There are often debates regarding the investigation of
choice for suspected pulmonary embolism occurring
during pregnancy, which is an important diﬀerential in a
breathless hypoxemic patient in pregnancy or the postpar-
tum period. In this patient, there was no evidence of pul-
monary thromboembolism, and if a VQ scan had not been
performed, the ﬁnding of reduced perfusion in the lower
lobes and VQ mismatch as a cause of the hypoxemia
would have been missed. It is notable that multiple studies
in breathless pregnant patients have shown> 80% to have
normal VQ scans in pregnancy, the remainder being diag-
nostic of pulmonary emboli.16,17 Subsequent investigation
with MR imaging with 3D-MR perfusion maps and MR
angiography conﬁrmed reduced perfusion in the lower
lobes in the absence of structural obstruction and no evi-
dence of a right to left shunt. Vasculitis can also lead to
reversible perfusion defects with a normal CT scan,18 but
her clinical presentation did not ﬁt this diagnosis and her
autoimmune screen was normal. To our knowledge, such
reversible pulmonary perfusion abnormalities have not
been described previously in the postpartum period.
In conclusion, we identify a mechanism (transiently
abnormal perfusion of unknown pathophysiology) that
may in part explain the high mortality seen in the postpar-
tum period in patients with PAH. In addition, the fact that
this patient has gone on to develop established PAH four
years later, emphasizes the signiﬁcance of an increase in
PAP over time, even if it remains within the normal range.
This should prompt consideration of continued follow-up in
patients with a family history of PAH who have borderline
elevated PAP.
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